3rd Annual Immuno-Oncology Summit Europe
-第3屆歐洲癌症免疫高峰會-
日期:2018年3月19-23日
地點:英國倫敦,Hilton Canary Wharf

會議日程

Adoptive T-Cell Therapy 
Combination Immunotherapy 
Immunomodulatory Antibodies 

關於活動

第3屆Immuno-Oncology Summit Europe由Cambridge Healthtech Institute (CHI)主辦,將在位於英國倫敦中心的Canary Wharf 舉行,針對尖端研究成果進行為期一週活絡的討論。高峰會由3組會議日程接連組成,能夠聆聽領導快速發展癌症生物治療藥物領域的研究團隊發表。第一組會議日程主題為T細胞輸入療法,聚焦利用CAR-T、TCR、TIL的次世代治療藥物及促進先天免疫系統參與的方法等議題。同時安排了會議討論T細胞基因工程技術、臨床前模型、生產方法,亦聚焦特異性及off-target毒性、安全性。緊接著登場的會議日程以併用免疫療法為主題,探討設計免疫療法合理併用法的策略及方法,介紹免疫調節組合、檢查點抑制劑及其他模態的併用、生物標記和以機制為基礎的併用癌症免疫療法選擇相關案例研討。最後一個日程則以具免疫調節機能的抗體為主題,將發表檢查點抑制劑、激動劑受體作用、NK細胞及巨噬細胞活性化、雙特異性抗體、Fc工程技術等領域之研究成果,並討論對檢查點抑制劑無反應的腫瘤課題。

上屆與會者回響

"The breadth and depth of the presentations was outstanding and resulted in many interesting conversations and contacts. This is what makes or breaks an event at the end of the day. The event, logistics and location were faultless too."
Senior Scientific Investigator, Systems Modeling and Translational Biology, GlaxoSmithKline

"Incredible line up of the brightest minds in immuno-oncology." 
Analyst, Aquilo Capital Management

"Thank you for the organizing such a great meeting. I enjoyed very much the wide coverage of talks from big and small pharma in the field of immuno-oncology." 
Senior Scientist, Cancer Immunotherapy Discovery, Roche Innovation Center Zurich

繼續閱讀